Uncommon clinical presentation of cystic fibrosis in a patient homozygous for a rare CFTR mutation: a case report

被引：0

作者：

Joanna Jaworska

Aleksandra Marach-Mocarska

Dorota Sands

机构：

[1] Institute of Mother and Child,

[2] Cystic Fibrosis Department,undefined

[3] Children’s Memorial Health Institute,undefined

[4] Department of Gastroenterology,undefined

[5] Hepatology,undefined

[6] Feeding Disorders and Pediatrics,undefined

来源：

BMC Pediatrics | / 20卷

关键词：

Cystic fibrosis; CF; Metabolic acidosis; Case report; Genetic testing;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[21] Clinical characteristics of rare CFTR mutations causing cystic fibrosis in Polish population [J].

Zybert, Katarzyna ;

Wozniacki, Lukasz ;

Tomaszewska-Sobczynska, Agnieszka ;

Wertheim-Tysarowska, Katarzyna ;

Czerska, Kamila ;

Oltarzewski, Mariusz ;

Sands, Dorota .

PEDIATRIC PULMONOLOGY, 2020, 55 (08) :2097-2107

[22] CiclosporinFolliculitis in a patient with cystic fibrosis: case report [J].

Reactions Weekly, 2008, 1199 (1) :17-17

[23] Clinical presentation of metabolic alkalosis in an adult patient with cystic fibrosis [J].

Sweetser, LJ ;

Douglas, JA ;

Riha, RL ;

Bell, SC .

RESPIROLOGY, 2005, 10 (02) :254-256

[24] The effect of CFTR modulators on a cystic fibrosis patient presenting with recurrent pancreatitis in the absence of respiratory symptoms: a case report [J].

Johns, J. Dixon ;

Rowe, Steven M. .

BMC GASTROENTEROLOGY, 2019, 19 (1)

[25] The effect of CFTR modulators on a cystic fibrosis patient presenting with recurrent pancreatitis in the absence of respiratory symptoms: a case report [J].

J. Dixon Johns ;

Steven M. Rowe .

BMC Gastroenterology, 19

[26] Clinical Effectiveness of Lumacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for F508del-CFTR A Clinical Trial [J].

Sagel, Scott D. ;

Khan, Umer ;

Heltshe, Sonya L. ;

Clancy, John P. ;

Borowitz, Drucy ;

Gelfond, Daniel ;

Donaldson, Scott H. ;

Moran, Antoinette ;

Ratjen, Felix ;

VanDalfsen, Jill M. ;

Rowe, Steven M. .

ANNALS OF THE AMERICAN THORACIC SOCIETY, 2021, 18 (01) :75-83

[27] Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E-CFTR mutation [J].

Berkers, Gitte ;

van der Meer, Renske ;

Heijerman, Harry ;

Beekman, Jeffrey M. ;

Boj, Sylvia F. ;

Vries, Robert G. J. ;

van Mourik, Peter ;

Doyle, Jamie R. ;

Audhya, Paul ;

Yuan, Zheng ;

Kinnman, Nils ;

van der Ent, C. Kors .

JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (05) :761-767

[28] Efficacy of lumacaftor-ivacaftor for the treatment of cystic fibrosis patients homozygous for the F508del-CFTR mutation [J].

Cholon, Deborah M. ;

Esther, Charles R., Jr. ;

Gentzsch, Martina .

EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2016, 1 (03) :235-243

[29] Heterogeneity of phenotype in two cystic fibrosis patients homozygous for the CFTR exon 11 mutation G551D [J].

Parad, RB .

JOURNAL OF MEDICAL GENETICS, 1996, 33 (08) :711-713

[30] Rare and unusual presentation of Cladophialophora infection in a pulmonary transplant cystic fibrosis patient [J].

Reynaud, Quitterie ;

Dupont, Damien ;

Nove-Josserand, Raphaele ;

Durupt, Stephane ;

Persat, Florence ;

Ader, Florence ;

Grenet, Dominique ;

Durieu, Isabelle .

TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (06)

← 1 2 3 4 5 →